Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$325K Sell
2,532
-10,352
-80% -$1.21M 0.03% 173
2026
Q1
$1.55M Buy
12,884
+310
+2% +$35.8K 0.13% 95
2025
Q4
$1.48M Buy
12,574
+9,879
+367% +$927K 0.12% 107
2025
Q3
$243K Hold
2,695
0.02% 168
2025
Q2
$226K Hold
2,695
0.02% 171
2025
Q1
$212K Hold
2,695
0.02% 163
2024
Q4
$269K Buy
+2,695
New +$278K 0.03% 148

Other funds holding MRK

Guardian Partners's MRK Position: Q2 2026 in Review

Guardian Partners reduced its Merck (MRK) stake by 80% in Q2 2026, selling an estimated $1.21M and leaving 2,532 shares worth $325K. The position accounts for 0.03% of the portfolio, ranked #173.

Guardian Partners first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.55M in Q1 2026. 3,839 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Guardian Partners held 2,532 shares of Merck worth $325K as of Q2 2026.
  • Guardian Partners sold 10,352 Merck shares in Q2 2026, an estimated $1.21M.
  • Merck made up 0.03% of Guardian Partners's portfolio in Q2 2026, its #173 holding.
  • Guardian Partners first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • Guardian Partners's Merck position peaked at $1.55M in Q1 2026.
  • 3,839 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Guardian Partners's 13F filing for Q2 2026, filed 29 Jul 2026.